{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:09:35Z","timestamp":1769166575175,"version":"3.49.0"},"reference-count":37,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T00:00:00Z","timestamp":1465689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Department of Research, Development and Education (FoUU), Halland Region, Sweden"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Shock is common in intensive care units, and treatment includes fluids, vasopressor and\/or inotropic drugs, guided by hemodynamic monitoring. The aim of this study was to identify current practice for treatment of shock in Scandinavian intensive care units.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seven\u2010day inception cohort study in 43 intensive care units in Scandinavia. Patients \u2265\u00a015\u00a0years old receiving more than 4\u00a0h of cardiovascular acting drug infusion were included. The use of fluids, vasopressor and inotropic drugs, type of monitoring, and target values were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and seventy\u2010one patients were included. At inclusion, 136\/168 (81%) had received vasopressor and\/or inotropic drug therapy for less than 24\u00a0h, and 143\/171 (84%) had received volume loading before the onset of vasoactive drug treatment. Ringer's solution was given to 129\/143 (90%) of patients and starches in 3\/143 (2%) patients. Noradrenaline was the most commonly used cardiovascular acting drug, given in 168\/171 (98%) of cases while dopamine was rarely used. Mean arterial pressure was considered the most important variable for hemodynamic monitoring. Invasive arterial blood pressure was monitored in 166\/171 (97%) of patients, arterial pulse wave analysis in 11\/171 (7%), and echocardiography in 50\/171 (29%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this survey, Ringer's solution and noradrenaline were the most common first\u2010line treatments in shock. The use of starches and dopamine were rare. Almost all patients were monitored with invasive arterial blood pressure, but comprehensive hemodynamic monitoring was used only in a minority of patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aas.12745","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T04:22:49Z","timestamp":1465791769000},"page":"945-957","source":"Crossref","is-referenced-by-count":5,"title":["Shock treatment in a cohort of Scandinavian intensive care units in 2014"],"prefix":"10.1111","volume":"60","author":[{"given":"M.","family":"Kollind","sequence":"first","affiliation":[{"name":"Department of Anaesthesia and Intensive Care Centalsjukhuset Kristianstad Kristianstad Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wickbom","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care Hallands Sjukhus Halmstad Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Wilkman","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency Medicine and Pain Medicine Helsinki University Central Hospital Helsinki Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S. C.","family":"Sn\u00e4ckestrand","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Intensive Care Sahlgrenska University Hospital Gothenburg Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Holm\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Research, Development and Education Region of Halland Halmstad Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oldner","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Surgical Services and Intensive Care Karolinska University Hospital Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Perner","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Copenhagen University Hospital \u2013 Rigshospitalet Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"\u00c5neman","sequence":"additional","affiliation":[{"name":"Intensive Care Unit Liverpool Hospital University of New South Wales Sydney NSW Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Chew","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Department of Medical and Health Sciences Link\u00f6ping University Hospital Link\u00f6ping Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Scandinavian Critical Care Trials Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,6,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000201896.45809.E3"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc9293"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00129.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2008.01690.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e3181c6ba6f"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31823778ee"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204242"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209759"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070716"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04211-2"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2769-8"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000727"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12429"},{"issue":"7","key":"e_1_2_7_16_1","first-page":"CD007594","article-title":"Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function","author":"Mutter TC","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet303"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc10291"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0967-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3525-z"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc9279"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3850-x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3878-y"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005866"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3849-3"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc9420"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000442"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404380"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401602"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500896"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-011-2246-9"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3228-5"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12490"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet442"},{"key":"e_1_2_7_36_1","unstructured":"Swedish Intensive Care Registry.http:\/\/www.icuregswe.org(accessed 15 March 2016)."},{"key":"e_1_2_7_37_1","unstructured":"Danish Intensive Care Registry.http:\/\/www.dasaim.dk\/did\/(accessed 15 March 2016)."},{"key":"e_1_2_7_38_1","unstructured":"Norwegian Intensive Care Registry.http:\/\/www.intensivregister.no(accessed 15 March 2016)."}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faas.12745","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aas.12745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:49:57Z","timestamp":1696499397000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aas.12745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,12]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1111\/aas.12745"],"URL":"https:\/\/doi.org\/10.1111\/aas.12745","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,12]]}}}